Bohring-Opitz syndrome (BOS) is a rare condition characterized by facial anomalies, multiple malformations, failure to thrive and severe intellectual disabilities. Recently, the cause was identified on the basis of de novo heterozygous mutations in the ASXL1 gene. We report on two novel cases carrying two previously undescribed mutations (c.2407_2411del5 [p.Q803TfsX17] and c.2893C>T [p.R965X]). These new data further support ASXL1 as cause of BOS and may contribute to a more precise definition of the phenotype caused by the disruption of this gene.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ajmg.a.35265 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ASXL1 truncating variants in BOS and myeloid leukemia drive shared disruption of Wnt-signaling pathways but have differential isoform usage of RUNX3.
BMC Med Genomics
November 2024
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Background: Rare variants in epigenes (a.k.a.
View Article and Find Full Text PDFRole of Nasopharyngeal Airway in Management of Craniofacial Syndrome-Associated Upper Airway Obstruction in Children.
Orthod Craniofac Res
November 2024
Department of Paediatric Respiratory and Sleep Medicine, Queensland Children's Hospital, South Brisbane, Australia.
Article Synopsis
- Upper airway obstruction (UAO) in infants, especially those with anatomical mid-face differences, is challenging to manage, and this study focuses on the use of a nasopharyngeal airway (NPA) as a treatment method.
- The study evaluated 67 infants who had NPA inserted, noting that a significant portion had various syndromes like Pierre Robin sequence, and found no complications from NPA usage.
- Results showed improved respiratory metrics after NPA insertion, indicating that it is an effective and safe noninvasive option for managing severe UAO in this population, with a call for more research to optimize treatment strategies.
ASXL1-related Bohring-Optiz syndrome complicated by persistent neonatal pulmonary hypertension and abnormal alveoli formation.
Eur J Med Genet
December 2024
Department of Pediatrics, Faculty of Medicine, Kagawa University, Kagawa, Japan. Electronic address:
Bohring-Opitz syndrome (BOS) is a rare disease with a characteristic facial appearance and limb position. This report describes a case of BOS complicated by persistent pulmonary hypertension of the newborn (PPHN) and formation of abnormal alveoli that was confirmed by autopsy. A female neonate was born by cesarean section at 37 weeks and 2 days of gestation and found to have a nevus flammeus, exophthalmos, abnormal palate, retraction of the mandible, and a posture characteristic of BOS.
View Article and Find Full Text PDFBohring-Opitz syndrome: Unraveling neonatal hypoglycemia and early detection through whole exome sequencing.
Pediatr Neonatol
November 2024
Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan. Electronic address:
Two cases of hepatoblastoma in Bohring-Opitz syndrome: An emerging association.
Pediatr Blood Cancer
July 2024
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!